Recent revelations and future directions using single-cell technologies in chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) is a clinically and biologically heterogeneous disease with varying outcomes. In the last decade, the application of next-generation sequencing technologies has allowed extensive mapping of disease-specific genomic, epigenomic, immunogenetic, and transcriptomic sig...
Main Authors: | Blaž Oder, Anastasia Chatzidimitriou, Anton W. Langerak, Richard Rosenquist, Cecilia Österholm |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1143811/full |
Similar Items
-
Editorial: The promise of immunogenetics for precision oncology
by: Elisavet Vlachonikola, et al.
Published: (2023-08-01) -
Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors
by: Chrysi Galigalidou, et al.
Published: (2021-11-01) -
T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword
by: Elisavet Vlachonikola, et al.
Published: (2021-01-01) -
Genetic and epigenetic variation in the lineage specification of regulatory T cells
by: Aaron Arvey, et al.
Published: (2015-10-01) -
Precision diagnostics in chronic lymphocytic leukemia: Past, present and future
by: John Mollstedt, et al.
Published: (2023-03-01)